The Governments of Canada and British Columbia (BC) signed the National Strategy for Drugs for Rare Diseases (DRD) agreement to invest a total amount of $194 million over three years to improve access to new drugs for rare diseases for its residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.